(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Mandarin Oriental Washington D.C.

Jan 25, 2016 8:30 AM - Jan 27, 2016 3:00 PM

1330 Maryland Avenue, SW, Washington, DC 20024

Pharmacovigilance and Risk Management Strategies 2016

Discuss opportunities, challenges, and practical aspects of managing risk in the context of benefits, for medical product safety and pharmacovigilance.

Back to Agenda

Session 1 - Keynote Address

Session Chair(s)

William Gregory, PhD

William Gregory, PhD

Senior Director, Safety and Risk Management

Pfizer Inc, United States

Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP

Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP

Strategy

Consultant, United Kingdom

Session 1 - Keynote Address

Speaker(s)

Mark B. McClellan, MD, PhD

Keynote - How Can Drug Safety Promote Innovation in Health Care?

Mark B. McClellan, MD, PhD

Duke-Margolis Center For Health Policy, United States

Director and Robert J. Margolis M.D. Professor of Business, Medicine and Policy

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.